Lower risk of hypoglycemic events with dapagliflozin than glipizide over 4 years in a phase 3 study

Category Primary study
ConferenceDiabetes
Year 2014
This article has no abstract
Epistemonikos ID: 6e37bb30c9211e8a10343b36529f0303c881bc62
First added on: Apr 30, 2026